Abstract
Background The Coronavirus disease 2019 (COVID-19) pandemic is considered a major global public health threat affecting across the life course and socioeconomic aspects of life. Globally acceptance to an effective vaccine is the most anticipated resolution. This study aims to evaluate intent to be vaccinated among public in Saudi Arabia during the second wave of COVID-19 pandemic.
Methods A cross-sectional web-based study was designed in Saudi Arabia. Study participants (N=658) were recruited through snowball sampling. SurveyMonkey platform was used to record the response. Cross-tabulation were performed by participants’ intention to vaccinate against COVID-19 virus with sociodemographic characteristics and respondents’ risk perception towards COVID-19, trust in the healthcare system, and their history of vaccine hesitancy behavior. Multivariable logistic regression analysis was performed to compute the predictors of vaccination intention among the study participants.
Results 658 participants were completed the survey (females = 47.4%). Of the 658 participants 351 (53.3%) have shown intent to be vaccinated. 519 (78.8%) of the participants were reported to be at high risk of COVID-19, and 307 (46.6%) were reported to trust the healthcare system in the country. The multivariable analysis shows respondents with a high-risk perception (OR: 2.27, 95% CI: 1.49-3.48); higher trust in the healthcare system (OR: 3.24, 95% CI: 2.32-4.61) was found to be the significant factor affecting the decision in acceptance of the COVID-19 vaccine in Saudi Arabia.
Conclusion Participants reported high knowledge towards COVID-19 virus, and vaccine developments. About half (46.6%) of the study participant reported refusal/hesitancy towards the vaccine during the second wave of the pandemic in Saudi Arabia. The study highlighted that higher risk perception and higher trust in the healthcare system were found to be the main reasons for participant’s intentions behind the vaccination.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nil
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was granted for the study by the institutional Research Ethics Committee (SEUREC-CHS20110) Saudi Electronic University, Riyadh, Kingdom of Saudi Arabia, and consent was taken before participation in the study. Anonymized data was used for analysis, interpretation, and reporting.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is available with the corresponding authors and provided up on request
